Data from the Scientific Report 2021
- 586 Projects
- 321 Clinical Trials
- 831 Publications
- 4702 Total Impact Factor
Researchers at IRSJD develop a method to predict the efficacy of a potent nanomedicine in a severe childhood cancer
Researchers at IRSJD have developed a method that predicts the anticancer efficacy of nab-paclitaxel, a well-known nanomedicine, in mouse models, for treatment of Ewing sarcoma, a severe cancer affecting the bones and soft tissue of children and adolescents.
Dr. Joan Comella, new director of the Institut de Recerca Sant Joan de Déu
The Governing Council of the Institute de Recerca Sant Joan de Déu (IRSJD) has appointed Dr. Joan Comella as director of the Institute. We thank Dr. Francesc Palau for his years of dedication to the management.
César Galo Garcia Fontecha
Head of the Orthopaedic Surgery and Traumatology Group
“Learning about what others are doing allows us to improve and develop new ideas in order to advance in the world of research.”
Read more More Interviews
#ViernesCientíficos · Juegos y gamificación en la docencia y la educación para la salud
Seminario a cargo de José Luis Gómez Urquiza. Doctor en Enfermería. Profesor titular del departamento de Enfermería de la Universidad de Granada (Campus Ceuta).
#MondaYmaging: seminari d'imatge mèdica | Assessment of physiological bone resorption of secondary alveolar bone graft by low-dose CT in patients with unilateral cleft lip and palate
Speakers: Marta Gómez Chiari and Martí Engli Rueda
Cleft lip and palate is the most frequent congenital craniofacial malformation (1:700 RN), and it is accompanied by other congenital deformities such as dental anomalies, facial hypoplasias and functional alterations, making its treatment complex and multitemporal. A fundamental part of the treatment is the alveolar graft for the reconstruction of the maxillary defect, providing continuity in the arch and supporting the nose.